Status:
UNKNOWN
Relevance of Peripheral Cells in the Pathophysiology of Chronic Myelomonocytic Leukemia (CMML)
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Chronic Myelomonocytic Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
Chronic Myelomonocytic Leukemia (CMML) is the most frequent of myelodysplastic/myeloproliferative syndromes, as defined by the WHO classification of myeloid malignancies. The median age at diagnosis i...
Eligibility Criteria
Inclusion
- Patients newly diagnosed or undergoing treatment in the Clinical Hematology department of the participating establishments
Exclusion
- NA
Key Trial Info
Start Date :
November 5 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 5 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03280888
Start Date
November 5 2014
End Date
November 5 2018
Last Update
March 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06000